---
layout: post
title: "Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting Complainant's Motion To Amend the Complaint and Notice of Investigation"
date: 2026-02-04 21:49:21 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-17924
original_published: 2025-09-17 00:00:00 +0000
significance: 8.00
---

# Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting Complainant's Motion To Amend the Complaint and Notice of Investigation

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 17, 2025 00:00 UTC
**Document Number:** 2025-17924

## Summary

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 15) of the presiding Chief administrative law judge ("Chief ALJ") granting Complainant's motion to amend the complaint and notice of investigation.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/17/2025-17924/certain-drug-products-containing-c-type-natriuretic-peptide-variants-and-components-thereof-notice)
- API: https://www.federalregister.gov/api/v1/documents/2025-17924

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
